StockData
Amesite Inc. logo

Amesite Inc. (AMST) company profile

AMSTNasdaqServices-Prepackaged SoftwareFiscal year ends June 30
Số liệu tài chính tới Q4 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/3033% below fair value
$0.55+0.07 (+15.12%)

Close on Nov 16, 2026Market cap $3.58MP/E –Yield –

About Amesite

Services-Prepackaged Software, SIC 7372

Amesite Inc. is a technology company that develops and commercializes artificial intelligence solutions, primarily for the post-acute healthcare sector. Its offerings comprise two primary product lines: NurseMagic and LynkMagic, alongside its Amesite Engage platform. NurseMagic includes a business-to-business enterprise application and a direct-to-consumer application for individual nurses and caregivers, providing documentation assistance, workflow simplification, electronic medical record compatibility, and automated reporting. LynkMagic delivers enterprise artificial intelligence solutions tailored to healthcare and related organizations for workflow, compliance, and operational oversight. The company serves individual healthcare professionals as well as healthcare businesses, including skilled nursing facilities, home health agencies, hospice organizations, and assisted living communities.

The company operates in the United States and has deployed its enterprise solutions to client populations including an approximately 2,700-patient census. Amesite is headquartered in Detroit, Michigan, and employs five full-time employees and one consultant as of June 30, 2026.

Summary of the business section of Amesite's latest annual report, written by StockData.

Company profile

Company

Legal name
Amesite Inc.
Founded
2017
Headquarters
Ann Arbor, MI
Address
205 East Washington Street, Suite B 48104
Phone
(650) 516-7633
Employees
5, Jun 30, 2026
Industry
Services-Prepackaged Software
Incorporated in
Delaware
Fiscal year ends
June 30
Auditor
Novogradac & Company LLP, Plantation, Florida

Stock & identifiers

Ticker
AMST
Exchange
Nasdaq
IPO date
Sep 28, 2020
Shares outstanding
7M, Sep 23, 2026
Public float
$9.00M, Dec 31, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company
Stock splits
1-for-12 reverse, Feb 22, 2023
SEC CIK
1807166
CUSIP
031094204
ISIN
US0310942042
FIGI
BBG00KY7FCW4
Share class FIGI
BBG00KY7FCX3
LEI
549300KJTPTB48X4PR54
EIN
82-3431717

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Ann Marie SastryCHIEF EXECUTIVE OFFICER, Director1,925,078
Sarah BermanCHIEF FINANCIAL OFFICER–
J. Michael LoshDirector179,866
Gilbert S. OmennDirector143,699
George ParmerDirector566,962
Barbie BrewerDirector135,977

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2026$560.50K$560.50K$137.08K$44–
FY2025$560.03K$560.03K$181.62K$90–

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2026

Summary compensation table from the latest proxy statement

ExecutiveSalaryOption awardsTotalvs. prior year
Ann Marie Sastry
Chief Executive Officer and President
$550.00K–$550.00K0%
Sarah Berman
Principal Financial and Accounting Officer
$75.00K$11.40K$86.40K+143%
Brandon Owens
Former Vice President of Sales (2)
$183.41K–$183.41K-22%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

IPO

From the final prospectus (Form 424B4) and the first day of trading

Offering

Type
Initial public offering
Final prospectus filed
Sep 28, 2020
Offer price
$5.00
Securities offered
3,000,000
Gross proceeds
$15.00M
Exchange
Nasdaq
First trading day
Sep 25, 2020
First-day close
$5.22+4.4%
Lock-up ends (est.)
Mar 24, 2021

“Per Share Total Initial public offering price $ 5.00 $ 15,000,000 Underwriting discounts and commissions (1) $ 0.40 $ 1,200,000 Proceeds to us, before expenses $ 4.60 $ 13,800,000 (1) Does not include a non-accountable expense allowance equal to 1% of the gross proceeds of this offering payable to underwriters.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.

Employees

Headcount reported in annual reports

“As of June 30, 2026, we have 5 full-time employees and 1 consultant.”

Corporate history

Events identified from SEC filings

See a number that looks wrong?